Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2 studies found for:    PRECOCIOUS PUBERTY, MALE-LIMITED
Show Display Options
Rank Status Study
1 Active, not recruiting
Has Results
Pediatrics Testotoxicosis Study [Bicalutamide Anastrozole Treatment for Testotoxicosis]
Condition: Puberty, Precocious
Interventions: Drug: Bicalutamide;   Drug: Anastrozole
2 Enrolling by invitation Natural History Study of Patients With Excess Androgen
Conditions: Congenital Adrenal Hyperplasia (CAH);   Familial Male-Limited Precocious Puberty (FMPP)
Intervention:

Study has passed its completion date and status has not been verified in more than two years.